Literature DB >> 22996285

TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.

Jia-Rong Meng1, Hui-Zhong Tang, Kai-Zong Zhou, Wu-Hong Shen, He-Yi Guo.   

Abstract

Trefoil factor 3 (TFF3) and survivin with functions of inhibiting apoptosis are involved in the gastric cancer by overexpression. The purpose of this study is to examine the expression of TFF3 and survivin in patients' tissue samples with gastric cancer and analyze the relationship between the protein expression and the different clinical records. By studying the expressions of TFF3 and survivin in gastric cancer through immunohistochemical staining and examining the survival rate via Kaplan-Meier analysis for gastric cancer patients, we found that the TFF3 and survivin positive expressions have a significant relationship with the lower survival rate comparing to that of negative expressions in the analyzed patients (P < 0.05). And moreover, patients with double positive TFF3 and survivin expressions have the lowest survival rate. TFF3 or survivin positive expression correlates with the lymph node metastasis, metastasis, and TNM stages of gastric cancer. Survival analysis indicates that survival rate has a close relationship with the age, tumor histology, tumor differentiation, degree of infiltration, lymph node metastasis, distant metastasis, and TNM stages (P < 0.01). Our data suggest that TFF3 and survivin expressions play a vital role in gastric cancer development, and these two proteins are important markers for prognosis in gastric cancer. Patients with gastric cancer can increase the survival rate through an earlier diagnosis and appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22996285     DOI: 10.1007/s10238-012-0210-9

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

1.  Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma.

Authors:  Takasuke Yamachika; J Lawrence Werther; Carol Bodian; Mark Babyatsky; Masae Tatematsu; Yoshitaka Yamamura; Anli Chen; Steven Itzkowitz
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

2.  TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells.

Authors:  Bayasi Guleng; Jia Han; Jin-Qiu Yang; Qing-Wen Huang; Jian-Kun Huang; Xiao-Ning Yang; Jing-Jing Liu; Jian-Lin Ren
Journal:  Mol Biol Rep       Date:  2011-07-17       Impact factor: 2.316

3.  Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.

Authors:  Dipok Kumar Dhar; Timothy C Wang; Hideki Tabara; Yasuhito Tonomoto; Riruke Maruyama; Mitsuo Tachibana; Hirofumi Kubota; Naofumi Nagasue
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

4.  Transcription factor NF-kappaB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells.

Authors:  Y H Chen; Y Lu; I G De Plaen; L Y Wang; X D Tan
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

5.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.

Authors:  J A Efstathiou; M Noda; A Rowan; C Dixon; R Chinery; A Jawhari; T Hattori; N A Wright; W F Bodmer; M Pignatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival.

Authors:  Loris Bertazza; Simone Mocellin; Alberto Marchet; Pierluigi Pilati; Joseph Gabrieli; Romano Scalerta; Donato Nitti
Journal:  J Transl Med       Date:  2009-12-22       Impact factor: 5.531

7.  Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions.

Authors:  Chun-Li Da; Yan Xin; Jing Zhao; Xiang-Dong Luo
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

8.  IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Authors:  I Tamm; Y Wang; E Sausville; D A Scudiero; N Vigna; T Oltersdorf; J C Reed
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

9.  Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.

Authors:  Steven F Moss; Jin-Woo Lee; Edmond Sabo; Anna K Rubin; John Rommel; Bruce R Westley; Felicity E B May; John Gao; Patricia A Meitner; Rose Tavares; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

10.  Increased expression of survivin in gastric cancer patients and in first degree relatives.

Authors:  J Yu; W K Leung; M P A Ebert; E K W Ng; M Y Y Go; H B Wang; S C S Chung; P Malfertheiner; J J Y Sung
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more
  17 in total

1.  Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis.

Authors:  Andreas Krieg; Billur Baseras; Monika Tomczak; Pablo Emilio Verde; Nikolas Hendrik Stoecklein; Wolfram Trudo Knoefel
Journal:  Mol Biol Rep       Date:  2013-08-15       Impact factor: 2.316

2.  Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients.

Authors:  Yong Li; Zhenqing Sun; Kewei Liu; Wensheng Qiu; Ruyong Yao; Tongtong Feng; Chao Xin; Lu Yue
Journal:  Mol Clin Oncol       Date:  2014-07-17

3.  Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.

Authors:  Hongfei Ge; Jonitha Gardner; Xiaosu Wu; Ingrid Rulifson; Jinghong Wang; Yumei Xiong; Jingjing Ye; Edward Belouski; Ping Cao; Jie Tang; Ki Jeong Lee; Suzanne Coberly; Xinle Wu; Jamila Gupte; Lynn Miao; Li Yang; Natalie Nguyen; Bei Shan; Wen-Chen Yeh; Murielle M Véniant; Yang Li; Helene Baribault
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

4.  TFF3 and HER2 expression and their correlation with survival in gastric cancer.

Authors:  Jianchun Gu; Leizhen Zheng; Li Zhang; Siyu Chen; Meiling Zhu; Xiaoping Li; Yajie Wang
Journal:  Tumour Biol       Date:  2014-12-17

Review 5.  Monitoring survivin expression in cancer: implications for prognosis and therapy.

Authors:  Rodrigo Santa Cruz Guindalini; Maria Cecília Mathias Machado; Bernardo Garicochea
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

6.  Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.

Authors:  Levent Dizdar; Monika Tomczak; Thomas A Werner; Sami A Safi; Jasmin C Riemer; Pablo E Verde; Nikolas H Stoecklein; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

7.  SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.

Authors:  Wonkyung Jung; Kwang Dae Hong; Woon Yong Jung; Eunjung Lee; Bong Kyung Shin; Han Kyeom Kim; Aeree Kim; Baek-Hui Kim
Journal:  Korean J Pathol       Date:  2013-08-26

8.  Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.

Authors:  Soyoung Im; Changyoung Yoo; Ji-Han Jung; Hyun Joo Choi; Jinyoung Yoo; Chang Suk Kang
Journal:  Int J Med Sci       Date:  2012-12-30       Impact factor: 3.738

Review 9.  Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.

Authors:  Jin Long Liu; Wei Gao; Qing Min Kang; Xue Jun Zhang; Shu Guang Yang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

10.  Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease.

Authors:  Ting-yi Du; Hui-ming Luo; Hai-chun Qin; Fang Wang; Qing Wang; Yang Xiang; Yun Zhang
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.